The Christ Hospital seeks volunteers for single-shot treatment that may fix high cholesterol
A Phase 2 clinical trial, "PULSE 1," is testing a one-time injection that researchers say could reduce LDL cholesterol by at least 60%.
Useful takeaways from this story.
A Phase 2 clinical trial, "PULSE 1," is testing a one-time injection that researchers say could reduce LDL cholesterol by at least 60%.
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
A Phase 2 clinical trial, "PULSE 1," is testing a one-time injection that researchers say could reduce LDL cholesterol by at least 60%.
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.